{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:36:22Z","timestamp":1768278982762,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.7759\/cureus.97836","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:02:12Z","timestamp":1764154932000},"source":"Crossref","is-referenced-by-count":1,"title":["Methotrexate-Induced Optic Neuropathy: A Rare and Under-Recognized Cause of Visual Loss in the Elderly"],"prefix":"10.7759","author":[{"given":"Mubshra","family":"Tariq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutbah Amin","family":"Khairati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narender","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Nafisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate an old drug with new tricks","volume":"20","author":"Bedoui Y","year":"2019","unstructured":"Bedoui Y, Guillot X, S\u00e9lambarom J, et al.. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019, 20:5023.","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092653","article-title":"Nutritional optic neuropathies: state of the art and emerging evidences","volume":"12","author":"Roda M","year":"2020","unstructured":"Roda M, di Geronimo N, Pellegrini M, Schiavi C. Nutritional optic neuropathies: state of the art and emerging evidences. Nutrients. 2020, 12:2653.","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-821751-1.00010-5","article-title":"Mitochondrial optic neuropathies","volume":"194","author":"Carelli V","year":"2023","unstructured":"Carelli V, La Morgia C, Yu-Wai-Man P. Mitochondrial optic neuropathies. Handb Clin Neurol. 2023, 194:23-42. 10.1016\/B978-0-12-821751-1.00010-5","journal-title":"Handb Clin Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1537689","article-title":"A review of clinical applications and side effects of methotrexate in ophthalmology","volume":"2020","author":"Wang G","year":"2020","unstructured":"Wang G, Peng X. A review of clinical applications and side effects of methotrexate in ophthalmology. J Ophthalmol. 2020, 2020:1537689. 10.1155\/2020\/1537689","journal-title":"J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00359-5","article-title":"Homocysteine and gliotoxicity","volume":"39","author":"Wyse AT","year":"2021","unstructured":"Wyse AT, Bobermin LD, Dos Santos TM, Quincozes-Santos A. Homocysteine and gliotoxicity. Neurotox Res. 2021, 39:966-74. 10.1007\/s12640-021-00359-5","journal-title":"Neurotox Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.wno.0000166061.73483.ce","article-title":"Reversible optic neuropathy associated with low-dose methotrexate therapy","volume":"25","author":"Clare G","year":"2005","unstructured":"Clare G, Colley S, Kennett R, Elston JS. Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol. 2005, 25:109-12. 10.1097\/01.wno.0000166061.73483.ce","journal-title":"J Neuroophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-2-299","article-title":"Folic acid deficiency optic neuropathy: a case report","volume":"2","author":"de Silva P","year":"2008","unstructured":"de Silva P, Jayamanne G, Bolton R. Folic acid deficiency optic neuropathy: a case report. J Med Case Rep. 2008, 2:299. 10.1186\/1752-1947-2-299","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard SC","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016, 21:1471-82. 10.1634\/theoncologist.2015-0164","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed KM","year":"2022","unstructured":"Hamed KM, Dighriri IM, Baomar AF, et al.. Overview of methotrexate toxicity: a comprehensive literature review. Cureus. 2022, 14:e29518. 10.7759\/cureus.29518","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11070958","article-title":"Neurological implications of vitamin B12 deficiency in diet: a systematic review and meta-analysis","volume":"11","author":"Alruwaili M","year":"2023","unstructured":"Alruwaili M, Basri R, AlRuwaili R, Albarrak AM, Ali NH. Neurological implications of vitamin B12 deficiency in diet: a systematic review and meta-analysis. Healthcare (Basel). 2023, 11:958. 10.3390\/healthcare11070958","journal-title":"Healthcare (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski A","year":"2015","unstructured":"Grzybowski A, Z\u00fclsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015, 93:402-10. 10.1111\/aos.12515","journal-title":"Acta Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60113","article-title":"Vision loss as a presenting symptom of vitamin B12 deficiency","volume":"16","author":"Othman I","year":"2024","unstructured":"Othman I, Tai E, Kuganasan S, Abu N. Vision loss as a presenting symptom of vitamin B12 deficiency. Cureus. 2024, 16:e60113. 10.7759\/cureus.60113","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein BN","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020, 16:145-54. 10.1038\/s41584-020-0373-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2009.04.004","article-title":"The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency","volume":"88","author":"Scalabrino G","year":"2009","unstructured":"Scalabrino G. The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency. Prog Neurobiol. 2009, 88:203-20. 10.1016\/j.pneurobio.2009.04.004","journal-title":"Prog Neurobiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-017-0646-5","article-title":"Role of homocysteine in cognitive impairement and Alzheimer\u2019s disease","volume":"33","author":"Bhargava S","year":"2018","unstructured":"Bhargava S, Bhandari A, Choudhury S. Role of homocysteine in cognitive impairement and Alzheimer\u2019s disease. Indian J Clin Biochem. 2018, 33:16-20. 10.1007\/s12291-017-0646-5","journal-title":"Indian J Clin Biochem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2024.2332366","article-title":"Risk factors associated with high-dose methotrexate induced toxicities","volume":"20","author":"Li W","year":"2024","unstructured":"Li W, Mo J, Yang Z, Zhao Z, Mei S. Risk factors associated with high-dose methotrexate induced toxicities. Expert Opin Drug Metab Toxicol. 2024, 20:263-74. 10.1080\/17425255.2024.2332366","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390553-methotrexate-induced-optic-neuropathy-a-rare-and-under-recognized-cause-of-visual-loss-in-the-elderly","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:02:13Z","timestamp":1764154933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390553-methotrexate-induced-optic-neuropathy-a-rare-and-under-recognized-cause-of-visual-loss-in-the-elderly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.97836","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}